Concepedia

Publication | Open Access

<i>EGFR</i> Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma

45

Citations

43

References

2019

Year

Abstract

<i>EGFR</i>-amplified cells are highly sensitive to talazoparib. Our data provide insight into the potential of using <i>EGFR</i> amplification as a selection biomarker for the development of personalized therapy.

References

YearCitations

Page 1